Efficacy of OKT3 as Primary Therapy for Histologically Confirmed Acute Renal Allograft Rejection in Simultaneous Kidney and Pancreas Transplant Recipients
- 1 March 1998
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 30 (2) , 285-287
- https://doi.org/10.1016/s0041-1345(97)01270-0
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipientsTransplantation Proceedings, 1997
- Clonidine, but not bradykinin or ANP, inhibits Na+ and water transport in Dahl SS rat CCDKidney International, 1993
- OKT3 FOR PRIMARY THERAPY OF THE FIRST REJECTION EPISODE IN KIDNEY TRANSPLANTSTransplantation, 1993
- A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal TransplantsNew England Journal of Medicine, 1985
- TREATMENT OF ACUTE RENAL ALLOGRAFT REJECTION WITH OKT3 MONOCLONAL ANTIBODYTransplantation, 1981